We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Affibody and Agilent to Develop Protein Sample

News   Sep 07, 2005

 
Affibody and Agilent to Develop Protein Sample
 
 
 

RELATED ARTICLES

Gene Editing Makes Mice Cocaine-Proof

News

A new paper has taken a ingenious route towards treating cocaine addicted mice – by developing a CRISPR-powered skin grafts that produce an anti-cocaine enzyme.

READ MORE

Allergy Driver Influences Brain Cell Communication

News

The chemotactic protein CCL17 attracts immune cells to where they are needed. Now scientists have discovered a completely new function: CCL17 also influences signal transmission in the brain.

READ MORE

Fatty Liver Disease Affects Cells' Energy Factories

News

Nonalcoholic fatty liver disease produces no noticeable symptoms, but one out of every five people with it will go on to develop a more serious conditions such as nonalcoholic steatohepatosis and cirrhosis. Three new studies investigate how mitochondrial energy production is altered by the progress of fatty liver disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE